Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From NuVasive, Inc.
The FDA said the benefits of the devices, which are used to prevent spinal deformity in children with thoracic insufficiency syndrome, outweigh their known risks.
Simplify’s total disc replacement complements NuVasive’s C360 line of cervical repair surgery devices, addressing a market that could eventually be worth $2.6bn.
Firms including Depuy Synthes, Medtronic Inc., and Zimmer Biomet Holdings Inc., spent thousands of dollars lobbying Congress last winter.
Global sales of orthobiologics products are expected to reach $2.8bn by 2024, a CAGR of 3.2%, led by the rising aging population and musculoskeletal disease.
- Implantable Devices
- Monitoring Equipment & Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
- Biotronic NeuroNetwork
- BNN Holdings Corp
- Ellipse Technologies, Inc.
- Impulse Monitoring, Inc.
- Mega Surgical
- NuVasive®, Inc
- NuVasive Clinical Services
- NuVasive Specialized Orthopedics, Inc.
- Simplify Medical, Inc.
- Vertera Spine